SEARCH

SEARCH BY CITATION

Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study

Celia J. A. Morgan, Leslie Muetzelfeldt & H. Valerie Curran

In the introduction of the above paper [1] ketamine was described as ‘an N-methyl-D-aspartate (NMDA: ecstasy) receptor antagonist’.

It was, of course, incorrect to include ‘ecstasy’ in this description.

We apologise for this error.

Reference

  1. Top of page
  2. Reference